PT1242395E - Esteres de acido benzoico de oxazolidinonas que possuem um substituinte hidroxiacetilpiperazina - Google Patents

Esteres de acido benzoico de oxazolidinonas que possuem um substituinte hidroxiacetilpiperazina

Info

Publication number
PT1242395E
PT1242395E PT00980849T PT00980849T PT1242395E PT 1242395 E PT1242395 E PT 1242395E PT 00980849 T PT00980849 T PT 00980849T PT 00980849 T PT00980849 T PT 00980849T PT 1242395 E PT1242395 E PT 1242395E
Authority
PT
Portugal
Prior art keywords
hydroxyacehylpyperazine
oxazolidinones
substituent
benzoic acid
acid esters
Prior art date
Application number
PT00980849T
Other languages
English (en)
Inventor
Jackson B Hester Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PT1242395E publication Critical patent/PT1242395E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT00980849T 1999-12-14 2000-12-06 Esteres de acido benzoico de oxazolidinonas que possuem um substituinte hidroxiacetilpiperazina PT1242395E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17067599P 1999-12-14 1999-12-14

Publications (1)

Publication Number Publication Date
PT1242395E true PT1242395E (pt) 2005-05-31

Family

ID=22620832

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00980849T PT1242395E (pt) 1999-12-14 2000-12-06 Esteres de acido benzoico de oxazolidinonas que possuem um substituinte hidroxiacetilpiperazina

Country Status (26)

Country Link
US (1) US6281210B1 (pt)
EP (1) EP1242395B1 (pt)
JP (1) JP2003516977A (pt)
KR (1) KR20020062332A (pt)
CN (1) CN1390211A (pt)
AR (1) AR026547A1 (pt)
AT (1) ATE288423T1 (pt)
AU (1) AU1805801A (pt)
BR (1) BR0015177A (pt)
CA (1) CA2387047A1 (pt)
CO (1) CO5261527A1 (pt)
CZ (1) CZ20022389A3 (pt)
DE (1) DE60017941T2 (pt)
EA (1) EA200200673A1 (pt)
ES (1) ES2236006T3 (pt)
HU (1) HUP0203787A3 (pt)
IL (1) IL150031A0 (pt)
MX (1) MXPA02005909A (pt)
NO (1) NO20022811D0 (pt)
PE (1) PE20010851A1 (pt)
PL (1) PL355369A1 (pt)
PT (1) PT1242395E (pt)
SK (1) SK5972002A3 (pt)
TW (1) TW544449B (pt)
WO (1) WO2001044212A1 (pt)
ZA (1) ZA200202953B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
US6833453B2 (en) * 2000-10-17 2004-12-21 Pharmacia & Upjohn Company Methods of producing oxazolidinone compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
ATE344036T1 (de) * 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
EP1934208B1 (de) 2005-10-04 2011-03-23 Bayer Schering Pharma Aktiengesellschaft Neue polymorphe form von 5-chlor-n-({ ( 5s )-2-0x0-3-[4-( 3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl} -methyl)-2-thiophencarboxamid
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
WO2008073444A2 (en) * 2006-12-12 2008-06-19 The Johns Hopkins University Phou (perf), a persistence switch involved in persister formation as a drug target for persister bacteria
CA2692255A1 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1046276C (zh) * 1993-11-22 1999-11-10 法玛西雅厄普约翰美国公司 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
ATE293609T1 (de) * 1997-05-30 2005-05-15 Upjohn Co Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
CA2387047A1 (en) 2001-06-21
CN1390211A (zh) 2003-01-08
NO20022811L (no) 2002-06-13
SK5972002A3 (en) 2003-01-09
BR0015177A (pt) 2002-06-18
CZ20022389A3 (cs) 2002-10-16
US6281210B1 (en) 2001-08-28
HUP0203787A2 (hu) 2003-07-28
AR026547A1 (es) 2003-02-19
ES2236006T3 (es) 2005-07-16
ATE288423T1 (de) 2005-02-15
HUP0203787A3 (en) 2005-06-28
MXPA02005909A (es) 2002-10-23
PL355369A1 (en) 2004-04-19
ZA200202953B (en) 2003-09-23
CO5261527A1 (es) 2003-03-31
DE60017941D1 (de) 2005-03-10
IL150031A0 (en) 2002-12-01
EP1242395A1 (en) 2002-09-25
AU1805801A (en) 2001-06-25
JP2003516977A (ja) 2003-05-20
TW544449B (en) 2003-08-01
WO2001044212A1 (en) 2001-06-21
EP1242395B1 (en) 2005-02-02
PE20010851A1 (es) 2001-08-17
EA200200673A1 (ru) 2002-12-26
DE60017941T2 (de) 2006-03-30
KR20020062332A (ko) 2002-07-25
NO20022811D0 (no) 2002-06-13

Similar Documents

Publication Publication Date Title
PT1242395E (pt) Esteres de acido benzoico de oxazolidinonas que possuem um substituinte hidroxiacetilpiperazina
EE05215B1 (et) Meetod tskloproplkarbokslhappe estrite ja derivaatide valmistamiseks
NO20030249D0 (no) Oksygenerte estere av 4-jod-fenylamino-benzohydroksamsyrer
ID22013A (id) Senyawa-senyawa ester
DK0823895T3 (da) Fedtsyreestere som bioaktive forbindelser
EE200200289A (et) Rasvhapete alküülestrite valmistamise meetod
PT1006795E (pt) Combinacoes fungicidas compreendendo derivados de acido fenilacrilico
DE60112229D1 (de) Celluloseester einer aromatischen Carbonsäure
PT1147080E (pt) Compostos de acido hidroxamico com alcinilo como inibidores de tace
PT1165503E (pt) Processo para a preparacao de esteres de acido hidroximetiltiobutirico
HUP0201766A3 (en) A process for obtaining (nitroxymethyl) phenyl esters of salicylic acid derivatives
PT1228026E (pt) Compostos relacionados com o acido 15-hidroxieicosatetraenoico
DK1212321T3 (da) Mellemprodukter til fremstilling af quinolone carboxylsyrederivater
NO993796L (no) Fremgangsmåte for omforestring av <alfa>- ketokarboksylsyreestre
PT1511741E (pt) Derivados éster de um ácido deca-hidroisoquinolino-3- carboxílico como analgésicos
DE50012694D1 (de) Verwendung von fettsäurealkanolaminestern
HK1049795A1 (zh) 用於治療動脈粥樣硬化的苯甲酸取代的苯並吡喃
SI1242395T1 (en) Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent
DE60010725T2 (de) Herstellung von arylcarbonsäureestern
NO20002988D0 (no) FremgangsmÕte for rensing av en oppløsning av ampicillin- prodrugester
ITMI991738A0 (it) Composizioni a rilascio controllato di acido acetilsalicilico
EE200200392A (et) Meetod arüüliminometüülkarbamiinhappeestrite valmistamiseks
DE60209436D1 (de) Alkyl Ester der 2-(2-Fluorosulfonyl)-perfluoroethylenoxy-3-halogen-Propionsäure
NO20013884D0 (no) Lipid A1-karboksylsyreanaloger av etertype
NO20025740D0 (no) Karbaminsyreestere som inhibitorer for faktor Xa